DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yang, SH | - |
dc.contributor.author | Lee, CG | - |
dc.contributor.author | Park, SH | - |
dc.contributor.author | Im, SJ | - |
dc.contributor.author | Kim, YM | - |
dc.contributor.author | Son, JM | - |
dc.contributor.author | Wang, JS | - |
dc.contributor.author | Yoon, SK | - |
dc.contributor.author | Song, MK | - |
dc.contributor.author | Ambrozaitis, A | - |
dc.contributor.author | Kharchenko, N | - |
dc.contributor.author | Yun, YD | - |
dc.contributor.author | Kim, CM | - |
dc.contributor.author | Kim, CY | - |
dc.contributor.author | Lee, SH | - |
dc.contributor.author | Kim, BM | - |
dc.contributor.author | Kim, WB | - |
dc.contributor.author | Sung, YC | - |
dc.date.accessioned | 2016-04-01T01:53:49Z | - |
dc.date.available | 2016-04-01T01:53:49Z | - |
dc.date.created | 2009-08-20 | - |
dc.date.issued | 2006-07 | - |
dc.identifier.issn | 0969-7128 | - |
dc.identifier.other | 2006-OAK-0000006036 | - |
dc.identifier.uri | https://oasis.postech.ac.kr/handle/2014.oak/23948 | - |
dc.description.abstract | Despite recent advances in the chemotherapy of chronic hepatitis B ( CHB), an effective viral suppression after cessation of therapy has not yet been achieved. To investigate whether hepatitis B virus ( HBV)-specific T-cell responses are inducible and can contribute to the viral suppression after cessation of the therapy, we conducted a proof-of-concept study with a DNA vaccine comprising of most HBV genes plus genetically engineered interleukin-12 DNA ( IL-12N222L) in 12 CHB carriers being treated with lamivudine ( LAM). When the ex vivo and/or cultured IFN-gamma enzyme-linked immunospot ( ELISPOT) assay was performed, the detectable HBV-specific IFN-gamma secreting T-cell responses were observed at the end of treatment and during a follow-up. These type 1T-cell responses, particularly CD4(+) memory T-cell responses could be maintained for at least 40 weeks after the therapy and correlated with virological responses, but not with alanine aminotransferase elevation. Moreover, DNA vaccination under LAM treatment appeared to be well-tolerated and showed 50% of virological response rate in CHB carriers. Thus, a combination therapy of the DNA vaccine with chemotherapy may be one of new immunotherapeutic methods for the cure of CHB. | - |
dc.description.statementofresponsibility | X | - |
dc.language | English | - |
dc.publisher | NATURE PUBLISHING GROUP | - |
dc.relation.isPartOf | GENE THERAPY | - |
dc.subject | hepatitis B virus | - |
dc.subject | DNA vaccine | - |
dc.subject | IL-12 | - |
dc.subject | T-cell response | - |
dc.subject | viral suppression | - |
dc.subject | DNA-MEDIATED IMMUNIZATION | - |
dc.subject | VIRUS-INFECTION | - |
dc.subject | LYMPHOCYTE RESPONSIVENESS | - |
dc.subject | TRANSGENIC MICE | - |
dc.subject | C VIRUS | - |
dc.subject | LAMIVUDINE | - |
dc.subject | INTERLEUKIN-12 | - |
dc.subject | VACCINE | - |
dc.subject | INDUCTION | - |
dc.subject | THERAPY | - |
dc.title | Correlation of antiviral T-cell responses with suppression of viral rebound in chronic hepatitis B carriers: a proof-of-concept study | - |
dc.type | Article | - |
dc.contributor.college | 생명과학과 | - |
dc.identifier.doi | 10.1038/sj.gt.3302751 | - |
dc.author.google | Yang, SH | - |
dc.author.google | Lee, CG | - |
dc.author.google | Park, SH | - |
dc.author.google | Im, SJ | - |
dc.author.google | Kim, YM | - |
dc.author.google | Son, JM | - |
dc.author.google | Wang, JS | - |
dc.author.google | Yoon, SK | - |
dc.author.google | Song, MK | - |
dc.author.google | Ambrozaitis, A | - |
dc.author.google | Kharchenko, N | - |
dc.author.google | Yun, YD | - |
dc.author.google | Kim, CM | - |
dc.author.google | Kim, CY | - |
dc.author.google | Lee, SH | - |
dc.author.google | Kim, BM | - |
dc.author.google | Kim, WB | - |
dc.author.google | Sung, YC | - |
dc.relation.volume | 13 | - |
dc.relation.issue | 14 | - |
dc.relation.startpage | 1110 | - |
dc.relation.lastpage | 1117 | - |
dc.contributor.id | 10053752 | - |
dc.relation.journal | GENE THERAPY | - |
dc.relation.index | SCI급, SCOPUS 등재논문 | - |
dc.relation.sci | SCI | - |
dc.collections.name | Journal Papers | - |
dc.type.rims | ART | - |
dc.identifier.bibliographicCitation | GENE THERAPY, v.13, no.14, pp.1110 - 1117 | - |
dc.identifier.wosid | 000238707800007 | - |
dc.date.tcdate | 2019-01-01 | - |
dc.citation.endPage | 1117 | - |
dc.citation.number | 14 | - |
dc.citation.startPage | 1110 | - |
dc.citation.title | GENE THERAPY | - |
dc.citation.volume | 13 | - |
dc.contributor.affiliatedAuthor | Sung, YC | - |
dc.identifier.scopusid | 2-s2.0-33745753413 | - |
dc.description.journalClass | 1 | - |
dc.description.journalClass | 1 | - |
dc.description.wostc | 77 | - |
dc.type.docType | Article | - |
dc.subject.keywordPlus | DNA-MEDIATED IMMUNIZATION | - |
dc.subject.keywordPlus | VIRUS-INFECTION | - |
dc.subject.keywordPlus | LYMPHOCYTE RESPONSIVENESS | - |
dc.subject.keywordPlus | TRANSGENIC MICE | - |
dc.subject.keywordPlus | C VIRUS | - |
dc.subject.keywordPlus | LAMIVUDINE | - |
dc.subject.keywordPlus | INTERLEUKIN-12 | - |
dc.subject.keywordPlus | VACCINE | - |
dc.subject.keywordPlus | INDUCTION | - |
dc.subject.keywordPlus | THERAPY | - |
dc.subject.keywordAuthor | hepatitis B virus | - |
dc.subject.keywordAuthor | DNA vaccine | - |
dc.subject.keywordAuthor | IL-12 | - |
dc.subject.keywordAuthor | T-cell response | - |
dc.subject.keywordAuthor | viral suppression | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Biotechnology & Applied Microbiology | - |
dc.relation.journalWebOfScienceCategory | Genetics & Heredity | - |
dc.relation.journalWebOfScienceCategory | Medicine, Research & Experimental | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Biotechnology & Applied Microbiology | - |
dc.relation.journalResearchArea | Genetics & Heredity | - |
dc.relation.journalResearchArea | Research & Experimental Medicine | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
library@postech.ac.kr Tel: 054-279-2548
Copyrights © by 2017 Pohang University of Science ad Technology All right reserved.